Carsten Moeller
Vice President & Head of Real World Evidence, Centre of Excellence Bayer
Excellence at Bayer, where he leads a global team of epidemiologists, outcomes experts, RWE researchers, and policy and partnership specialists. His work focuses on advancing integrated approaches to evidence generation across Bayer’s portfolio, connecting lifecycle needs, stakeholder priorities, data sources, and methodologies to strengthen the impact of real-world evidence.
Prior to his current role, Carsten led Integrated Evidence Generation across Bayer’s Women’s Healthcare, Inflammation and Immunology portfolios, developing cross-functional strategies and operating models to advance asset value through RWE. He also brings extensive experience in market access, HTA and payer engagement, having led global access strategies and early scientific advice across multiple therapeutic areas. With nearly two decades at Bayer, Carsten combines RWE leadership with deep expertise in evidence strategy, market access, and pharmaceutical development.
Seminars
- Explore how federated data networks can help connect fragmented real-world data sources and enable research across different countries and healthcare systems
- Discuss the practical considerations involved in working across multiple data sources, including differences in data availability, structure, quality and access
- Examine how evolving research needs are creating demand for more connected and granular real-world data, and what this means for the future of RWE generation
